Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
A completed clinical trial evaluating the long-term effects of treatments given to children previously treated for Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [Phase 1]
Phase 1 clinical trial evaluating donor T-helper 2 (Th2) cell therapy to prevent graft-versus-host disease after bone marrow transplantation…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Music & Cancer - Live Music During Chemotherapy [NA]
This clinical trial update reports the completion of a study evaluating live music during chemotherapy for patients with non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
The National Cancer Institute-sponsored clinical trial assessing relapse in malignant blood cancers after allogeneic hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]
Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating panobinostat with everolimus in recurrent hematologic malignancies including multiple myeloma and non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating the combination of chemotherapy with low-dose radiation therapy for Stage I or Stage IIA Hodgkin lymphoma; the tria…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin in Hodgkin lymphoma patients unsuitable for chemotherapy due to age, frailty, or comorbidity; t…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating allogeneic blood stem cell transplantation with adoptive immunotherapy for Hodgkin lymphoma has completed and poste…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin before autologous stem cell transplant in Hodgkin lymphoma; the study has completed with result…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]
Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating alisertib in combination with vorinostat in adults with relapsed or recurrent Hodgkin lymphoma, B-cell non-Hodgkin …
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating S0816 FDG F-18 PET/CT imaging with or without additional chemotherapy and G-CSF in stage III/IV Hod…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 trial from Massachusetts General Hospital evaluating recipient leukocyte infusions to prevent donor graft rejection after nonmyelo…
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
A completed clinical trial at St. Jude’s Research Hospital assessing brain integrity in Hodgkin lymphoma survivors treated with thoracic rad…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update of a vaccine therapy in patients with Hodgkin lymphoma after first-line therapy; the study was terminated an…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin as pre-ASCT induction therapy in relapsed/refractory Hodgkin's lymphoma patients who did not re…
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating dose-dense ABVD as first-line therapy for early-stage unfavorable Hodgkin lymphoma, sponsored by Fo…
-
CLINICAL_TRIALS trial_result · 2018-02-08Clinical Trial Update: High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating high-dose chemotherapy and stem cell transplantation in PET-2 positive Hodgkin's lymphoma after ABVD, with compar…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating autologous stem cell transplant followed by donor stem cell transplant in relapsed or refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial assessing filgrastim with chemotherapy followed by peripheral stem cell transplant in Hodgkin lymphoma and Non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating biological therapies following peripheral stem cell transplantation in patients with non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improv…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma [NA]
Clinical trial evaluating induction chemotherapy with ABVD followed by brentuximab vedotin consolidation in newly diagnosed, non-bulky stage…